Clinical Trials
6 trialsNCT07234877 2026-06-04
Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Not yet recruiting
NCT06702826 2024-11-25
Cadonilimab Combined With Stereotactic Radiotherapy as Second-line Treatment for Brain Metastases
Xiangya Hospital of Central South University
Phase 2 Recruiting
NCT03075072 2024-10-23
Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT03754530 2018-11-27
Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT02950792 2017-08-25
MRI Adaptive Replanning Using ViewRay
University of Miami
Phase NA Withdrawn
NCT02972333 2016-11-23
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M
Shandong Cancer Hospital and Institute
Phase 3 Unknown